April 3, 2019
Kowa filed a new lawsuit against Towa Pharmaceutical with the Tokyo District Court seeking additional damages of around 4.5 billion yen related to Towa’s generic version of the hypercholesterolemia treatment Livalo (pitavastatin). Towa said on April 2 that it received...read more